Scaling Legends

Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast

19 min · 4 de jul de 2026
Portada del episodio Novo Nordisk's $4.1 Billion Bet: How BE&K Just Won the Biggest Pharma Build in the Southeast

Descripción

Novo Nordisk is investing $4.1 billion in a 1.4-million-square-foot, 10-building manufacturing expansion in Clayton, North Carolina to ramp Ozempic and Wegovy production — and BE&K Building Group just landed the build as Design-Builder and Agency Construction Manager across a 56-acre campus. We break down why life-sciences construction is the new megaproject gold rush, how the design-build delivery model changes who wins subcontracts, and how mid-market contractors can position for phased 2027-2

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Scaling Legends!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

233 episodios